September 27, 2025 · Form 4 insider transaction
DOYLE THOMAS JAMES bought 24,966 shares of Kura Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Includes 1,211 shares acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.